SABBY MANAGEMENT, LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607950. A total of 6 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$1,067,000
-88.7%
76
-91.2%
0.16%
-92.3%
Q4 2018$9,429,000
-35.7%
864
-4.8%
2.07%
+10.5%
Q3 2018$14,665,000
+22.2%
9080.0%1.88%
+1.2%
Q2 2018$12,002,000
-8.8%
908
-48.9%
1.85%
+136.2%
Q1 2018$13,158,000
+60.7%
1,776
+20.7%
0.78%
+5.2%
Q4 2017$8,190,000
+248.5%
1,472
+184.2%
0.75%
+384.4%
Q3 2017$2,350,000
+958.6%
518
+684.8%
0.15%
+926.7%
Q2 2017$222,000
-99.6%
66
-99.7%
0.02%
-99.5%
Q4 2016$52,805,000
-67.9%
19,251
-28.0%
3.07%
-50.1%
Q3 2016$164,259,000
+194.5%
26,748
-8.6%
6.15%
+111.5%
Q2 2016$55,780,000
+223.9%
29,250
+231.5%
2.91%
+237.6%
Q1 2016$17,224,000
+35.2%
8,824
+167.2%
0.86%
+23.0%
Q4 2015$12,739,000
+116.1%
3,302
+79.8%
0.70%
+188.5%
Q3 2015$5,895,000
+15.5%
1,836
+9.5%
0.24%
+30.6%
Q2 2015$5,103,000
+292.5%
1,677
+71.3%
0.19%
+244.4%
Q1 2015$1,300,000
+45.6%
979
+131.4%
0.05%
+58.8%
Q3 2014$893,000
-82.3%
423
-75.0%
0.03%
-84.3%
Q2 2014$5,043,000
-48.3%
1,693
-58.3%
0.22%
-60.5%
Q1 2014$9,756,000
-35.9%
4,060
-45.7%
0.55%
-43.7%
Q4 2013$15,223,000
-75.3%
7,473
-42.6%
0.97%
-75.7%
Q3 2013$61,531,000
+195.6%
13,028
+138.1%
4.00%
+187.9%
Q2 2013$20,817,0005,4711.39%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
BOOTHBAY FUND MANAGEMENT, LLC 962$16,401,0000.61%
GROUP ONE TRADING, L.P. 183,600$31,302,0000.05%
SIMPLEX TRADING, LLC 950$16,196,0000.02%
JPMORGAN CHASE & CO 417,600$71,197,0000.01%
IMC-Chicago, LLC 33,800$5,763,0000.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SAREPTA THERAPEUTICS INC shareholders